Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOXACAT
2024-517739-35-00Phase 3Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acute acoustic trauma (AAT) comparing Hyperbaric oxygen 5 days twice daily with Hyperbaric oxygen 10 days once daily (standard of care) (2 arms). Primary endpoint: Absolute average hearing gain at one month. Started Oct 2024; status: completed.
02
Drugs
oxygen
03
Conditions
acute acoustic trauma (AAT)
Beyond the preview
Go deeper on 2024-517739-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517739-35-00.